Back
Innate Pharma SA Vs. Arcellx Industry Stock Comparison
Sell
49
IPHA
Innate Pharma SA
Last Price:
$2.05
Seasonality Move:
-8.32%
Sell
42
ACLX
Arcellx
Last Price:
$64.58
Seasonality Move:
29.9%
Sell
49
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.09. The Score for IPHA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
IPHA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Arcellx (ACLX)
is a Sell
Is Arcellx a Buy, Sell or Hold?
-
ACLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing slight buying pressure.
ACLX Stock Price Chart
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 59.73 | Buy |
Chaikin Money Flow: | 5860 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.81 - 1.99) | Buy |
Bollinger Bands (100): | (1.7 - 2.14) | Buy |
ACLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 52.58 | Buy |
Chaikin Money Flow: | 15652 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.31 - 67.71) | Buy |
Bollinger Bands (100): | (61.35 - 77.51) | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.98 | Buy |
20-day SMA: | 1.9 | Buy |
50-day SMA: | 1.99 | Buy |
200-day SMA: | 2 | Buy |
8-day EMA: | 1.99 | Buy |
20-day EMA: | 1.95 | Buy |
50-day EMA: | 1.94 | Buy |
200-day EMA: | 2.04 | Buy |
ACLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.83 | Buy |
20-day SMA: | 61.21 | Buy |
50-day SMA: | 65.15 | Sell |
200-day SMA: | 73.14 | Sell |
8-day EMA: | 63.01 | Buy |
20-day EMA: | 62.89 | Buy |
50-day EMA: | 65.14 | Sell |
200-day EMA: | 68.61 | Sell |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arcellx Earnings Growth & ACLX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.52 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.52 per share, and an increase next year of $0.50 per share.
Innate Pharma SA Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arcellx Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |